SIFI to expand in France with new subsidiary & first time participation in SFO 2018 Congress
SIFI welcomes eye experts to the Congress of the Société Française d'Ophtalmologie in May
Paris May 4th, 2018 - SIFI, the Italian leader in the development of therapeutic solutions to treat ophthalmic disorders, is pleased to announce the establishment of its wholly owned subsidiary SIFI France SAS, located in Rueil Malmaison (Paris) and its first ever participation at a French ophthalmic meeting, namely in the Société Française d'Ophtalmologie Congress, taking place from May 5th to 8th at the Palais des Congrès in Paris.
In the last years SIFI has significantly grown its international business exporting innovative pharma and medtech products. With the recent opening of its French offices, SIFI is proud to export tradition and quality abroad, and to be recognized today as an example of Italian technological excellence in pharma manufacturing, production and export.
This year's topics at SFO 2018 will include the current state of the art and future in cataract surgery, innovations and therapies regarding the retina and new surgical treatments for glaucoma. Furthermore the Annual report "Emergencies in Ophthalmology" will be presented during this International event, which will include guests and speakers from all over the world, more than 100 exhibitors, several symposia and hundreds of eye experts travelling to France for this special occasion.
During this meeting SIFI will be present with a company booth and in addition will be organizing a Symposium with focus on "Factors of success in the management of the ocular surface & Extended Depth of Focus intraocular lenses for cataract refractive surgery" which will take place on Saturday May 5th 2018 at 6.30 PM. Focal issues will be management of antibiotic resistance in ocular surgery, new trends in the management of the ocular surface and the use of extended depth of focus technology as a new opportunity for presbyopia.
"We are strengthening the company’s organizational infrastructure across different geographies and the recent opening of our subsidiary is the first milestone in our long-term plan for France. SIFI is going to deploy significant resources and stamina in a strategic effort to address one of the biggest and most competitive markets in Western Europe." said Fabrizio Chines, SIFI Chairman & CEO. "SIFI looks forward to bringing innovative therapeutic options to French ophthalmologists and surgeons, leveraging on more than 80 years of know-how and history."
SIFI is the leading Italian ophthalmic company, focused on eye care since 1935. SIFI designs, manufactures and markets innovative pharmaceutical specialty products, surgical and medical devices. Headquartered in Catania, Sicily, SIFI operates directly in Italy, Romania and Mexico with a staff of more than 370 people worldwide. Since June 2015, SIFI is backed by 21 Investimenti, a private equity firm founded by Alessandro Benetton, which supports the company’s international expansion and portfolio development strategy. More information available at www.sifigroup.com.
For information please contact Press & Communication SIFI SpA
c/o CITYnet - Rome